Replies to post #1675 on AmStem Corporation (fka AMST)

[MinnieM]

An excerpt from the 9/1/10 pr:
http://finance.yahoo.com/news/Stem-Cell-Industry-Leader-iw-2377685120.html?x=0&.v=1

"The company is now wrapping up the accounting challenge of merging Histostem into AmStem. The process has proven to be more arduous than originally thought. However KPMG is making excellent progress and I am confident we will return to fully reporting status by early in the fourth quarter.

"In addition to restoring AmStem's position as a fully reporting company, I have several priorities as president. I expect to announce shortly a new Scientific and Medical Board of Advisors. The announcement of this group will substantially underscore the seriousness with which our company must be taken.

"We are moving to get product into the market and build our revenue stream. I have no doubt that SteMixx and other cosmeceutical products will find excellent market acceptance. Equally exciting are the prospects for major medical innovations that will help find wonderful solutions to a large variety of medical problems. In addition, we are going to be more actively interfacing with the financial community to explain our company and its exciting prospects including the various vertical revenue channels we are developing. I personally expect to begin meeting with investors in the months ahead."

In Reply To 'alexander77'

15 September is nearing. By then we'll have the financial report.